What are SBIR and STTR Programs?
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are one of the largest sources of early-stage capital for innovative small companies in the United States. These programs allow US-owned and operated small businesses to engage in federal research and development (R&D) that has a strong potential for commercialization.
In Fiscal Year 2015, NIH’s SBIR and STTR programs will invest over 780 million dollars into early-stage, health and life science companies that are creating a wide range of innovative technologies that align with NIH’s mission to improve health and save lives. A key objective of this work is translating promising technologies to the private sector through strategic public and private partnerships, so that life-saving innovations reach consumer markets.
We invite you to explore our website to learn more about NIH's SBIR & STTR programs, or get started on an application!
The NIH SBIR program funds early stage small businesses that are seeking to commercialize innovative biomedical technologies. This competitive program helps small businesses participate in federal research and development, develop life-saving technologies, and create jobs.
The NIH STTR program is similar to the NIH SBIR program, but requires that the small business formally collaborate with a research institution in Phase I and Phase II. Learn more about the NIH SBIR and STTR programs, including their critical differences.